JPMorgan Chase & Co’s Apyx Medical APYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-60
Closed -$82 6157
2025
Q1
$82 Sell
60
-5
-8% -$7 ﹤0.01% 6026
2024
Q4
$103 Sell
65
-2
-3% -$3 ﹤0.01% 5948
2024
Q3
$83 Hold
67
﹤0.01% 5958
2024
Q2
$90 Sell
67
-3
-4% -$4 ﹤0.01% 5884
2024
Q1
$95 Sell
70
-753
-91% -$1.02K ﹤0.01% 5898
2023
Q4
$2.16K Sell
823
-157,039
-99% -$411K ﹤0.01% 5675
2023
Q3
$505K Sell
157,862
-6,155
-4% -$19.7K ﹤0.01% 3719
2023
Q2
$825K Sell
164,017
-278,077
-63% -$1.4M ﹤0.01% 3535
2023
Q1
$1.27M Buy
442,094
+134,835
+44% +$388K ﹤0.01% 3298
2022
Q4
$719K Buy
307,259
+237,621
+341% +$556K ﹤0.01% 3556
2022
Q3
$313K Sell
69,638
-13,438
-16% -$60.4K ﹤0.01% 3977
2022
Q2
$487K Sell
83,076
-75,356
-48% -$442K ﹤0.01% 3899
2022
Q1
$1.04M Sell
158,432
-25,235
-14% -$165K ﹤0.01% 3584
2021
Q4
$2.36M Sell
183,667
-1,178
-0.6% -$15.1K ﹤0.01% 3128
2021
Q3
$2.56M Sell
184,845
-57,487
-24% -$796K ﹤0.01% 3013
2021
Q2
$2.5M Sell
242,332
-574,290
-70% -$5.92M ﹤0.01% 3088
2021
Q1
$7.89M Buy
816,622
+175,242
+27% +$1.69M ﹤0.01% 2317
2020
Q4
$4.62M Buy
641,380
+34,817
+6% +$251K ﹤0.01% 2479
2020
Q3
$2.85M Sell
606,563
-48,959
-7% -$230K ﹤0.01% 2563
2020
Q2
$3.64M Buy
655,522
+537,084
+453% +$2.98M ﹤0.01% 2352
2020
Q1
$425K Buy
118,438
+107,456
+978% +$386K ﹤0.01% 3359
2019
Q4
$93K Sell
10,982
-40,103
-79% -$340K ﹤0.01% 4052
2019
Q3
$346K Buy
51,085
+7,035
+16% +$47.6K ﹤0.01% 3498
2019
Q2
$264K Sell
44,050
-129,371
-75% -$775K ﹤0.01% 3658
2019
Q1
$1.09M Buy
173,421
+101,366
+141% +$639K ﹤0.01% 2981
2018
Q4
$467K Sell
72,055
-51,009
-41% -$331K ﹤0.01% 3412
2018
Q3
$874K Buy
123,064
+32,228
+35% +$229K ﹤0.01% 3240
2018
Q2
$395K Buy
90,836
+72,736
+402% +$316K ﹤0.01% 3552
2018
Q1
$54K Buy
+18,100
New +$54K ﹤0.01% 4122
2017
Q4
Sell
-1,996
Closed -$7K 4646
2017
Q3
$7K Buy
+1,996
New +$7K ﹤0.01% 4093